.png){kind=logo}
Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Mar 20, 2025Medtronic Smart MDI system includes unique early notification feature for missed meal boluses and high glucose that enables users to bolus on time. Consistent response to these notifications was associated with Time in Range of 67% and 71%, respectively.Medtronic plc, a global leader in medical technology, presented today the first real-world data on the use of its latest Smart MDI system, which combines the InPen™ smart insulin pen with the...
Mar 6, 2025The company will present clinical evidence at ATTD exploring challenges faced by women living with type 1 diabetes, from menstruation to pregestational diabetesMedtronic plc, the global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming 18th International Conference on Advanced Technologies and...
Nov 20, 2024New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses.Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance for its new InPen™ app featuring missed meal dose...
- Nov 18, 2024With its Meal Detection Technology™* and autocorrections every 5 minutes, Medtronic is expanding outcomes to populations in Asia and empowering patients to achieve greater glycemic control, especially during mealtimes.
Medtronic, a global leader in healthcare technology, today shared new clinical and real-world evidence on the MiniMed™ 780G system from the Asia Pacific region demonstrating its ability to...
- Nov 7, 2024New data from Australia, Japan, India, Singapore, Hong Kong, and South Korea demonstrates the MiniMed™ 780G is driving consistent clinical outcomes in diabetes management.
Medtronic plc, a global leader in medical technology, announced new clinical and real-world data to be presented at the inaugural Asian Conference on Innovative Therapies for Diabetes Management...
Oct 4, 2024Customers are being notified of the importance of checking built-in alerts and alarms for battery status and to contact Medtronic for pump replacement if affected by this issueMedtronic plc (NYSE: MDT), a global leader in healthcare technology, voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700...
- Sep 4, 2024The company will present clinical evidence in young children, pregnancy and type 2 diabetes*
Medtronic plc, the global leader in medical technology, announced it will present new data on its MiniMed™ 780G system at the upcoming European Association for the Study of Diabetes (EASD) 60th...
- Aug 7, 2024Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) —...
- Jun 21, 2024With its advanced algorithm that provides autocorrections every 5 minutes, the latest data demonstrated that the MiniMed™ 780G system decreased rates of early morning hyperglycemia, known as dawn phenomenon, and improved overnight sleep
Medtronic plc (NYSE: MDT), a global leader in healthcare technology, is presenting a comprehensive body of new data at the American Diabetes Association's (ADA) 84th Scientific Sessions that...
Jun 4, 2024Dr. Petrovski’s expertise will further strengthen Medtronic clinical and scientific activities to help people with diabetes live better with technologyMedtronic, a global leader in healthcare technology, today announced that Dr. Goran Petrovski M.D., Ph.D. has joined the company’s Diabetes Operating Unit as Medical Affairs Director. Dr....